- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/34 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving hydrolase
Patent holdings for IPC class C12Q 1/34
Total number of patents in this class: 1483
10-year publication summary
97
|
87
|
109
|
84
|
81
|
80
|
63
|
66
|
74
|
63
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19898 |
38 |
Halozyme, Inc. | 143 |
28 |
Centre National de La Recherche Scientifique | 10421 |
18 |
BioMarin Pharmaceutical Inc. | 376 |
17 |
The Board of Trustees of the Leland Stanford Junior University | 6402 |
15 |
The University of Tokyo | 4173 |
14 |
The General Hospital Corporation | 4726 |
13 |
Duke University | 3064 |
13 |
Becton, Dickinson and Company | 7259 |
12 |
Massachusetts Institute of Technology | 10051 |
11 |
Alectos Therapeutics Inc. | 49 |
11 |
New England BioLabs, Inc. | 494 |
11 |
Neogen Food Safety US Holdco Corporation | 149 |
11 |
Shimadzu Corporation | 6165 |
9 |
Cornell University | 3302 |
9 |
Promega Corporation | 571 |
9 |
Merck Sharp & Dohme Corp. | 2197 |
8 |
Novozymes A/S | 3320 |
8 |
American Sterilizer Company | 660 |
8 |
Amicus Therapeutics, Inc. | 349 |
8 |
Other owners | 1212 |